Goldenrod Therapeutics, Inc.
PrivateLast Round
Seed
Jun 3, 2026
Total Funding Raised
$920,000
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Goldenrod Therapeutics, Inc. is a biotechnology company developing next-generation, brain-penetrant phosphodiesterase 4 (PDE4) inhibitors for serious neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Goldenrod Therapeutics, Inc. Comparables
Compare Goldenrod Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Enthorin Therapeutics | 83% | |
| Shionogi & Co. | 74% | |
| PTC Therapeutics Inc | 69% |
Goldenrod Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jun 3, 2026 | ||||
| Grant | Nov 5, 2024 | ||||
| Grant | Oct 10, 2024 | ||||
| Grant | Jul 14, 2021 |
Goldenrod Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| United States Department of Defense | Grant |
| Fannin Innovation Studio | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 3, 2026
$3.2M seed round completed.
- Oct 10, 2024
Secured $320K in grant funding.
Goldenrod Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Goldenrod Therapeutics, Inc.'s valuation, stock price, and market status.
Is Goldenrod Therapeutics, Inc. a public or private company?
Goldenrod Therapeutics, Inc. is a private company.
What is the current stock price of Goldenrod Therapeutics, Inc.?
Goldenrod Therapeutics, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Goldenrod Therapeutics, Inc. worth (valuation)?
Valuation information for Goldenrod Therapeutics, Inc. is not publicly available.
Can I buy Goldenrod Therapeutics, Inc. stock?
Goldenrod Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Goldenrod Therapeutics, Inc.'s last funding round?
Goldenrod Therapeutics, Inc.'s most recent funding round was Seed on June 3, 2026.
Who are the main investors in Goldenrod Therapeutics, Inc.?
Key investors in Goldenrod Therapeutics, Inc. include Fannin Innovation Studio.
Will Goldenrod Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for Goldenrod Therapeutics, Inc..
How can I track Goldenrod Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Goldenrod Therapeutics, Inc.'s secondary market activity and sign up for updates.